This site is for informational purposes only and does not provide medical advice, diagnosis, or treatment. Always consult your healthcare provider.
A Study of Xaluritamig Plus Abiraterone Versus Investigator's Choice in Participants With Chemotherapy-naïve Metastatic Castration-resistant Prostate Cancer | MicrobiomeTrials
← Back to trials NCT07213674
A Study of Xaluritamig Plus Abiraterone Versus Investigator's Choice in Participants With Chemotherapy-naïve Metastatic Castration-resistant Prostate Cancer Recruiting PHASE3 INTERVENTIONAL
Read the full scientific description See full eligibility requirements Trial Details Start: 2025-11-28Est. Completion: 2030-01-07
Enrollment target: 750 participantsLocations City of Hope Cancer Center Phoenix, Goodyear, Arizona, United States City of Hope National Medical Center, Duarte, California, United States City of Hope Orange County Lennar Foundation Cancer Center, Duarte, California, United States Providence Saint Jude Medical Center, Fullerton, California, United States Providence Saint Johns Health Center, Santa Monica, California, United States Rocky Mountain Cancer Centers, Denver, Colorado, United States Medical Oncology Hematology Consultants Helen F Graham Cancer Center, Newark, Delaware, United States Moffitt Cancer Center, Tampa, Florida, United States City of Hope Atlanta, Newnan, Georgia, United States University of Illinois Chicago, Chicago, Illinois, United States Midwestern Regional Medical Center dba City of Hope Chicago, Zion, Illinois, United States University of Kansas Medical Center, Westwood, Kansas, United States University of Louisville Health - James Graham Brown Cancer Center, Louisville, Kentucky, United States Norton Cancer Institute, Louisville, Kentucky, United States Other microbiome trials you might be interested in Metastatic Castration-resistant Prostate Cancer
The purpose of this study is to evaluate the efficacy and safety of 177Lu-TLX591 in patients with metastatic castration-…
Orange, United States Est. completion Dec 2027
Advanced HR+/HER2- Breast Cancer Advanced CCNE1-amplified Solid Tumors Metastatic Castration-resistant Prostate Cancer
Phase I: Characterize safety and tolerability of GVV858 as a single agent and in combination with fulvestrant or letrozo…
Nashville, United States Est. completion May 9, 2031
University of Maryland Greenebaum Cancer Center, Baltimore, Maryland, United States
Johns Hopkins Hospital Sidney Kimmell Comprehensive Cancer Center, Baltimore, Maryland, United States
Barbara Ann Karmanos Cancer Institute, Lansing, Michigan, United States
Minnesota Oncology Hematology PA, Minneapolis, Minnesota, United States
University of Minnesota Medical Center Fairview, Minneapolis, Minnesota, United States
Hematology Oncology Association of Central New York, East Syracuse, New York, United States
Oncology Hematology Care Incorporated, Cincinnati, Ohio, United States
Hightower Clinical, Oklahoma City, Oklahoma, United States
University of Pittsburgh Medical Center, Pittsburgh, Pennsylvania, United States
United States Oncology Regulatory Affairs Corporate Office, Nashville, Tennessee, United States
The Center for Cancer and Blood Disorders, Arlington, Texas, United States
Texas Oncology Northeast Texas, Tyler, Texas, United States
US Oncology Research Investigational Products Center, Tyler, Texas, United States
University of Virginia Cancer Center, Charlottesville, Virginia, United States
Virginia Cancer Specialists PC, Leesburg, Virginia, United States
Virginia Oncology Associates, Norfolk, Virginia, United States
Calvary Mater Newcastle Hospital, Waratah, New South Wales, Australia
Icon Cancer Care Wesley, Herston, Queensland, Australia
Tasman Oncology Research, Southport, Queensland, Australia
Monash Medical Centre, Clayton, Victoria, Australia
Austin Health, Austin Hospital, East Melbourne, Victoria, Australia
Ordensklinikum Linz Elisabethinen, Linz, Austria
Universitaetsklinikum Sankt Poelten, Sankt Pölten, Austria
Krankenhaus der Barmherzigen Brueder Wien, Vienna, Austria
Universitaetsklinikum Allgemeines Krankenhaus Wien, Vienna, Austria
Universite Catholique de Louvain Cliniques Universitaires Saint Luc, Brussels, Belgium
Universitair Ziekenhuis Gent, Ghent, Belgium
Universitair Ziekenhuis Leuven - Campus Gasthuisberg, Leuven, Belgium
Centre Hospitalier Universitaire Dinant Godinne - Universite Catholique de Louvain Namur, Yvoir, Belgium
Centre de Recherche du Centre Hospitalier de l Universite de Montreal, Montreal, Quebec, Canada
Sir Mortimer B Davis - Jewish General Hospital, Montreal, Quebec, Canada
CIUSSS de l Estrie CHUS Hopital Fleurimont, Sherbrooke, Quebec, Canada
Centre Hospitalier Universitaire de Bordeaux - Hopital Saint Andre, Bordeaux, France
Institut Bergonie, Bordeaux, France
Centre Regional Francois Baclesse, Caen, France
Centre Jean Perrin, Clermont-Ferrand, France
Clinique Victor Hugo - Centre Jean Bernard, Le Mans, France
Centre Leon Berard, Lyon, France
Centre Antoine Lacassagne, Nice, France
Groupe Hospitalier Paris Saint Joseph, Paris, France
Hopital Europeen Georges Pompidou, Paris, France
Centre Hospitalier Universitaire de Strasbourg - Hopital de Hautepierre, Strasbourg, France
Hopital Foch, Suresnes, France
Institut Universitaire du Cancer Toulouse Oncopole, Toulouse, France
Gustave Roussy, Villejuif, France
Charite - Universitaetsmedizin Berlin, Campus Mitte, Berlin, Germany
Universitaetsklinikum Bonn, Bonn, Germany
Universitaetsklinikum Dresden, Dresden, Germany
Uniklinikum Erlangen, Erlangen, Germany
Universitaetsklinikum Essen, Essen, Germany
Universitaetsklinikum Hamburg Eppendorf, Hamburg, Germany
Universitaetsklinikum Heidelberg, Heidelberg, Germany
Universitatsklinikum Jena, Jena, Germany
Universitaetsklinikum Schleswig-Holstein - Kiel, Kiel, Germany
Universitaetsklinikum Ulm, Ulm, Germany
Universitaetsklinikum Wuerzburg, Würzburg, Germany
University General Hospital of Alexandroupoli, Alexandroupoli, Greece
Henry Dunant Hospital Center, Athens, Greece
Alexandra Hospital, Athens, Greece
Attikon University Hospital, Athens, Greece
University Hospital of Heraklion, Heraklion - Crete, Greece
General Oncological Hospital of Kifisia Oi Agioi Anargyroi, Kifissia, Athens, Greece
Athens Medical Center S.A - Iatriko Amarousiou, Marousi, Greece
European Interbalkan Medical Center, Thessaloniki, Greece
Azienda Ospedaliero Universitaria Ospedali Riuniti di Foggia, Foggia, Italy
IRCCS Ospedale San Raffaele, Milan, Italy
Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy
Azienda Ospedaliera Universitaria di Modena Policlinico, Modena, Italy
Azienda Ospedaliera Universitaria San Luigi Gonzaga, Orbassano, Italy
Ospedale Pederzoli Casa di Cura Privata, Peschiera del Garda, Italy
IRCCS Istituto Clinico Humanitas, Rozzano, Italy
Ospedale Santa Chiara Azienda Sanitaria Universitaria Integrata del Trentino, Trento, Italy
Nagoya University Hospital, Nagoya, Aichi-ken, Japan
National Hospital Organization Shikoku Cancer Center, Matsuyama, Ehime, Japan
Kyushu University Hospital, Fukuoka, Fukuoka, Japan
Kobe University Hospital, Kobe, Hyōgo, Japan
Kanazawa University Hospital, Kanazawa, Ishikawa-ken, Japan
Kagawa University Hospital, Kita-gun, Kagawa-ken, Japan
Kitasato University Hospital, Sagamihara-shi, Kanagawa, Japan
Osaka International Cancer Institute, Osaka, Osaka, Japan
The University of Osaka Hospital, Suita-shi, Osaka, Japan
Saitama Medical University International Medical Center, Hidaka-shi, Saitama, Japan
Dokkyo Medical University Saitama Medical Center, Koshigaya-shi, Saitama, Japan
Nippon Medical School Hospital, Bunkyo-ku, Tokyo, Japan
The Cancer institute Hospital of Japanese Foundation for Cancer Research, Koto-ku, Tokyo, Japan
The Jikei University Hospital, Minato-ku, Tokyo, Japan
Toyama University Hospital, Toyama, Toyama, Japan
Universitair Medisch Centrum Groningen, Groningen, Netherlands
Hospital da Luz, SA, Lisbon, Portugal
Unidade Local de Saude de Santa Maria, EPE - Hospital de Santa Maria, Lisbon, Portugal
Instituto Portugues de Oncologia do Porto Francisco Gentil, EPE, Porto, Portugal
Unidade Local de Saude de Sao Joao, EPE - Hospital de Sao Joao, Porto, Portugal
Unidade Local de Saude de Gaia-Espinho, EPE, Vila Nova de Gaia, Portugal
National University Hospital, Singapore, Singapore
National Cancer Centre Singapore, Singapore, Singapore
Tan Tock Seng Hospital, Singapore, Singapore
Seoul National University Hospital, Seoul, South Korea
Severance Hospital Yonsei University Health System, Seoul, South Korea
Asan Medical Center, Seoul, South Korea
Hospital Clinico Universitario Virgen de la Victoria, Málaga, Andalusia, Spain
Hospital Regional Universitario de Malaga, Málaga, Andalusia, Spain
Hospital Clinic i Provincial de Barcelona, Barcelona, Catalonia, Spain
Hospital de la Santa Creu i Sant Pau, Barcelona, Catalonia, Spain
Complexo Hospitalario Universitario A Coruna Hospital Teresa Herrera, A Coruña, Galicia, Spain
Hospital Universitario Lucus Augusti, Lugo, Galicia, Spain
Hospital Universitario Puerta de Hierro Majadahonda, Majadahonda, Madrid, Spain
Clinica Universidad de Navarra, Pamplona, Navarre, Spain
Hospital Universitari Vall d Hebron, Barcelona, Spain
Hospital Universitario Ramon y Cajal, Madrid, Spain
Hospital Clinico San Carlos, Madrid, Spain
Hospital Universitario 12 de Octubre, Madrid, Spain
Inselspital Bern, Bern, Switzerland
Centre Hospitalier Universitaire Vaudois, Lausanne, Switzerland
Kantonsspital Sankt Gallen, Sankt Gallen, Switzerland
Hirslanden Zurich, Zurich, Switzerland
Kaohsiung Medical University Chung-Ho Memorial Hospital, Kaohsiung City, Taiwan
Taichung Veterans General Hospital, Taichung, Taiwan
National Cheng Kung University Hospital, Tainan, Taiwan
National Taiwan University Hospital, Taipei, Taiwan
Guys Hospital, London, United Kingdom
Sarah Cannon Research Institute UK, London, United Kingdom
Royal Marsden Hospital, Sutton, United Kingdom